Modulation of cellular apoptosis with Apoptotic protease-activating factor 1 (Apaf-1) inhibitors

Journal of Medicinal Chemistry

Volumn 51, Issue 3, 2008, Pages 521-529

  Mondragon L ^a   Orzaez M ^a   Sanclimens, G ^b   Moure, A ^b   Arminan A ^a   Sepulveda P ^a,c   Messeguer, A ^b   Vicent, M J ^a   Perez Paya E ^a,d  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^b DEPARTMENT OF ENVIRONMENTAL CHEMISTRY   (Spain)

^c HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^d INSTITUTO DE BIOMEDICINA DE VALENCIA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSOME; APOPTOSOME INHIBITOR; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; APOPTOTIC PROTEASE ACTIVATING FACTOR 1 INHIBITOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL DEATH; CELL HYPOXIA; CONTROLLED STUDY; ENZYME INHIBITION; HEART MUSCLE CELL; HISTIOCYTIC LYMPHOMA; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; MITOCHONDRIAL MEMBRANE; MOLECULAR MODEL; NEWBORN; NONHUMAN; OSTEOSARCOMA; PROTEIN BINDING; PROTEIN MODIFICATION; RAT;

ANIMALS; ANIMALS, NEWBORN; APOPTOSIS; APOPTOSOMES; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; CARRIER PROTEINS; CELL HYPOXIA; CELLS, CULTURED; HUMANS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MOLECULAR CONFORMATION; MYOCYTES, CARDIAC; PEPTIDE FRAGMENTS; PEPTOIDS; POLYGLUTAMIC ACID; PROTEIN BINDING; RATS; TAT GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;

EID: 39149123189     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm701195j     Document Type: Article

References (37)

1. Fesik, S. W. Promoting apoptosis as a strategy for cancer drug discovery. Nat. Rev. Cancer 2005, 5, 876-885.
2. Nencioni, A.; Grunebach, F.; Patrone, F.; Ballestrero, A.; Brossart, P. The proteasome and its inhibitors in immune regulation and immune disorders. Crit. Rev. Immunol. 2006, 26, 487-497.
3. Fischer, U.; Schulze-Osthoff, K. New approaches and therapeutics targeting apoptosis in disease. Pharmacol. Rev. 2005, 57, 187-215.
4. Takemura, G.; Fujiwara, H. Morphological aspects of apoptosis in heart diseases. J. Cell. Mol. Med. 2006, 10, 56-75.
5. Mattson, M. P.; Kroemer, G. Mitochondria in cell death: novel targets for neuroprotection and cardioprotection. Trends Mol. Med. 2003, 9, 196-205.
6. Siegel, R. M. Caspases at the crossroads of immune-cell life and death. Nat. Rev. Immunol. 2006, 6, 308-317.
7. Chai, J. J.; Du, C. Y.; Wu, J. W.; Kyin, S.; Wang, X. D.; et al. Structural and biochemical basis of apoptotic activation by Smac/DIABLO. Nature 2000, 406, 855-862.
8. Li, P.; Nijhawan, D.; Budihardjo, I.; Srinivasula, S. M.; Ahmad, M.; et al. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade. Cell 1997, 91, 479-489.
9. Martin, A. G.; Nguyen, J.; Wells, J. A.; Fearnhead, H. O. Apo cytochrome c inhibits caspases by preventing apoptosome formation. Biochem. Biophys. Res. Commun. 2004, 319, 944-950.
10. Schafer, Z. T.; Kornbluth, S. The apoptosome: physiological, developmental, and pathological modes of regulation. Dev. Cell 2006, 10, 549-561.
11. Mochizuki, H.; Hayakawa, H.; Migita, M.; Shibata, M.; Tanaka, R.; et al. An AAV-derived Apaf-1 dominant negative inhibitor prevents MPTP toxicity as antiapoptotic gene therapy for Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 2001, 98, 10918-10923.
12. Cao, G. D.; Xiao, M.; Sun, F. Y.; Xiao, X.; Pei, W.; et al. Cloning of a novel Apaf-1-interacting protein: a potent suppressor of apoptosis and ischemic neuronal cell death. J. Neurosci. 2004, 24, 6189-6201.
13. Malet, G.; Mart́in, A. G.; Orzáez, M.; Vicent, M. J.; Masip, I.; et al. Small molecule inhibitors of Apaf-1-related caspase-3/-9 activation that control mitochondrial-dependent apoptosis. Cell Death Differ. 2006, 13, 1523-1532.
14. Orzaez, M.; Mondragon, L.; Marzo, I.; Sanclimens, G.; Messeguer, A.; et al. Conjugation of a novel Apaf-1 inhibitor to peptide-based cell-membrane transporters: effective methods to improve inhibition of mitochondria-mediated apoptosis. Peptides 2007, 28, 958-968.
15. Vicent, M. J.; Pérez-Payá, E. Poly-L-glutamic acid (PGA) aided inhibitors of apoptotic protease activating factor 1 (Apaf-1): an antiapoptotic polymeric nanomedicine. J. Med. Chem. 2006, 49, 3763-3765.
16. Tsujimoto, Y. Role of Bcl-2 family proteins in apoptosis: apoptosomes or mitochondria. Genes Cells 1998, 3, 697-707.
17. Chan, S. L.; Yu, V. C. Proteins of the bcl-2 family in apoptosis signalling: from mechanistic insights to therapeutic opportunities. Clin. Exp. Pharmacol. Physiol. 2004, 31, 119-128.
18. Duncan, R. Drug polymer conjugates - potential for improved chemotherapy. Anti-Cancer Drugs 1992, 3, 175-210.
19. Lademann, U.; Cain, K.; Gyrd-Hansen, M.; Brown, D.; Peters, D.; et al. Diarylurea compounds inhibit caspase activation by preventing the formation of the active 700-kilodalton apoptosome complex. Mol. Cell. Biol. 2003, 23, 7829-7837.
20. Nguyen, J. T.; Wells, J. A. Direct activation of the apoptosis machinery as a mechanism to target cancer cells. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 7533-7538.
21. Bras, M.; Queenan, B.; Susin, S. A. Programmed cell death via mitochondria: different modes of dying. Biochemistry (Moscow) 2005, 70, 231-239.
22. Green, D. R. Apoptotic pathways: ten minutes to dead. Cell 2005, 121, 671-674.
23. Martinou, I.; Desagher, S.; Eskes, R.; Antonsson, B.; Andre, E.; et al. The release of cytochrome c from mitochondria during apoptosis of NGF-deprived sympathetic neurons is a reversible event. J. Cell Biol. 1999, 144, 883-889.
24. Seye, C. I.; Knaapen, M. W. M.; Daret, D.; Desgranges, C.; Herman, A. G. 7-Ketocholesterol induces reversible cytochrome c release in smooth muscle cells in absence of mitochondrial swelling. Cardiovasc. Res. 2004, 64, 144-153.
25. Anversa, P.; Cheng, W.; Liu, Y.; Leri, A.; Redaelli, G.; et al. Apoptosis and myocardial infarction. Basic Res. Cardiol. 1998, 93, 8-12.
26. Itoh, G.; Tamura, J.; Suzuki, M.; Suzuki, Y.; Ikeda, H. DNA fragmentation of human infarcted myocardial cells demonstrated by the nick end labeling method and DNA agarose gel electrophoresis. Am. J. Pathol. 1995, 146, 1325-1331.
27. Schwarz, K.; Simonis, G.; Yu, X.; Wiedemann, S.; Strasser, R. H. Apoptosis at a distance: remote activation of caspase-3 occurs early after myocardial infarction. Mol. Cell. Biochem. 2006, 281, 45-54.
28. Fliss, H.; Gattinger, D. Apoptosis in ischemic and reperfused rat myocardium. Circ. Res. 1996, 79, 949-956.
29. Gottlieb, R. A.; Engler, R. L. Apoptosis in myocardial ischemia-reperfusion. Ann. N.Y. Acad. Sci. 1999, 874, 412-426.
30. Wang, G. W.; Zhou, Z.; Klein, J. B.; Kang, Y. J. Inhibition of hypoxia/reoxygenation-induced apoptosis in metallothionein-overexpressing cardiomyocytes. Am. J. Physiol.: Heart Circ Physiol. 2001, 280, H2292-H2299.
31. Ferrari, R. Metabolic disturbances during myocardial ischemia and reperfusion. Am. J. Cardiol. 1995, 76, 17B-24B.
32. Lucas, D. T.; Szweda, L. I. Declines in mitochondrial respiration during cardiac reperfusion: age-dependent inactivation of alpha-ketoglutarate dehydrogenase. Proc. Natl. Acad. Sci. U.S.A. 1999, 96, 6689-6693.
33. Wencker, D.; Chandra, M.; Nguyen, K.; Miao, W. F.; Garantziotis, S.; et al. A mechanistic role for cardiac myocyte apoptosis in heart failure. J. Clin. Invest. 2003, 111, 1497-1504.
34. Hayakawa, Y.; Chandra, M.; Miao, W. F.; Shirani, J.; Brown, J. H.; et al. Inhibition of cardiac myocyte apoptosis improves cardiac function and abolishes mortality in the peripartum cardiomyopathy of G alpha q transgenic mice. Circulation. 2003, 108, 3036-3041.
35. Masip, I.; Cortes, N.; Abad, M. J.; Guardiola, M.; Perez-Paya, E.; et al. Design and synthesis of an optimized positional scanning library of peptoids: identification of novel multidrug resistance reversal agents. Bioorg. Med. Chem. 2005, 13, 1923-1929.
36. Kijima, K.; Matsubara, H.; Murasawa, S.; Maruyama, K.; Mori, Y.; et al. Mechanical stretch induces enhanced expression of angiotensin II receptor subtypes in neonatal rat cardiac myocytes. Circ. Res. 1996, 79, 887-897.
37. Sgouras, D.; Duncan, R. Methods for the evaluation of biocompatibility of soluble synthetic-polymers which have potential for bio-medical use. 1. Use of the tetrazolium-based colorimetric assay (Mtt) as a preliminary screen for evaluation of invitro cytotoxicity. J. Mater. Sci.: Mater. Med. 1990, 1, 61-68.